Eddie Cliff is an Australian haematology registrar with academic interests in health policy, lymphoid malignancies, and public health. He is currently at Harvard doing a fellowship with PORTAL (Program on Regulation, Therapeutics and Law), to help advocate for lower prices for drugs and make them more accessible. In this podcast we talk about healthcare funding, health policy, clinical trials, polatuzumab, and the implications of VITT on the future of adenoviral vector vaccines. Read more about Eddie here:https://www.hsph.harvard.edu/news/features/bringing-heart-and-humanity-to-hematology/